Investigational drug · Phase 2
SAR444836
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Phenylketonuria.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 23, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "SAR444836"
First trial start
2023
Aug 7, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "SAR444836", any sponsor or status.
Conditions studied
As listed on its trial records.
- Phenylketonuria
Approved drugs for the same conditions: Phenylketonuria (PKU) · Rare and genetic disease
Largest trials
Live from ClinicalTrials.gov: studies naming "SAR444836" as an intervention, largest first.
- A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With PhenylketonuriaActive, not recruiting
SanofiSanofi (SNY)
NCT05972629 · 32 participants (planned) · Start Aug 7, 2023 · Primary completion Apr 2, 2030
Drug: SAR444836 · For: Phenylketonuria
Sites: San Francisco, California; Aurora, Colorado; Gainesville, Florida · 11 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Phenylketonuria
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Sanofi.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.